Learnings from the First R-Based Submission to FDA by Novo Nordisk
Novo Nordisk stands as a trailblazer in R-based submissions to the FDA, having recently completed the inaugural submission in this statistical programming language to regulatory authorities. This milestone was achieved at the close of 2021, encompassing the inclusion of SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) datasets, programs, ...
Continue reading: Learnings from the First R-Based Submission to FDA by Novo Nordisk
http://dlvr.it/T13Dct
Continue reading: Learnings from the First R-Based Submission to FDA by Novo Nordisk
http://dlvr.it/T13Dct

تعليقات
إرسال تعليق